US officials defend swine flu vaccination plan
* Senators call U.S. response confusing, misinformed
* Officials say decisions must be made at local level (Adds HHS comment paragraphs 12-14)
By Maggie Fox, Health and Science Editor
WASHINGTON, Nov 17 (Reuters) - U.S. public health officials defended the distribution of swine flu vaccines on Tuesday against criticism that their plan to protect Americans was confusing and over-optimistic.
Manufacturers have delivered 48.5 million doses of H1N1 vaccine, Dr. Anne Schuchat of the U.S. Centers for Disease Control and Prevention told a Senate hearing. HHS had hoped to have as many as 120 million doses by now.
The problem was worsened because the first vaccine to be available was a nasal spray made by AstraZeneca (AZN.L) unit MedImmune that is not suitable for some of the most vulnerable groups but which is perfect for most schoolchildren and healthcare workers, officials said.
Members of the Senate Homeland Security and Governmental Affairs Committee pressed for an apology and said they felt President Barack Obama's administration had not learned some valuable lessons from the continuing problem.
"I am worried that we are undermining confidence in our public health system," said committee chairman, Connecticut independent Sen. Joseph Lieberman.
He said he feared people who have waited in vain to be vaccinated against H1N1 swine flu will stop trying.
"This hearing is critical to peeling away the layers of misinformation and miscommunication that has hampered the federal government's pandemic influenza strategy," added Maine Republican Senator Susan Collins.
The U.S. government is struggling to vaccinate as many people as possible against the virus, which has infected an estimated 22 million Americans and killed 3,900.
In September HHS Secretary Kathleen Sebelius had assured Congress, "There will be enough vaccines for everyone."
"I think we led expectations of availability to be higher than they have been. I think that led to frustration," Schuchat said.
ADMITTING MISTAKES
"I think you used the word mistake and it is important to acknowledge that here," Lieberman said.
HHS spokeswoman Jenny Backus later said Sebelius's promise was not a mistake.
"The problem has been that lots of people want it all at the same time and that has been a challenge and we understand that people are frustrated," Backus said by email.
"Vaccine came off the production lines slower than what the original predictions were and we made the tough choice to start the vaccination program as soon as vaccine was ready to go even though we knew that supplies would be low."
The vaccination plan was chosen at a July meeting of the Advisory Committee on Immunization Practices, an independent group of experts that advises the CDC on vaccine policies.
They agreed to create five broad priority groups totaling 159 million people -- pregnant women, healthcare workers, people with asthma or other conditions that put them at high risk of flu complications, caregivers of infants too young to be vaccinated, and children and adults aged up to 24.
Lieberman said he thought HHS and CDC should have revised the priority groups downward to the 42 million people deemed most in need of vaccination, but Schuchat said the committee met again in October and decided not to modify its recommendations.
"What we heard pretty consistently was leave the flexibility to the state and locals. Let them decide," she said. Many wanted to run school-based clinics and narrowing the designated priority groups would have meant the most available vaccine -- the spray -- could not be broadly used. (Editing by Alan Elsner)
Source: Reuters
« Back to Health News
Related News
-
Flu pandemic could be mild Nov 18, 2009 @ 06:15 AM
With the second wave of H1N1 infections having crested in the United States, leading epidemiologists are predicting that the pandemic could end up ranking as the mildest since modern medicine began documenting influenza outbreaks.
-
Officials Defend Handling of Flu Vaccine Nov 18, 2009 @ 06:15 AM
As a nationwide shortage of swine flu vaccine stretched into its sixth week, federal health officials defended how they handled the program, arguing that the roots of the shortage were beyond their control and that they had made the right decisions on matters they could affect.
-
Liquid form of drug used to treat youngest victims of swine flu is in short supply Nov 18, 2009 @ 06:15 AM
First it was the rush for hand sanitizer. Then it was the quest for the vaccine. Now, as increasing numbers of children are coming down with swine flu, more parents are facing yet another anxiety-provoking chase: the hunt for liquid Tamiflu for kids.
-
Swine flu-related deaths up in region Nov 18, 2009 @ 06:15 AM
Maryland confirmed two more swine flu-related deaths Wednesday, bringing the state's total to 12. The death toll in Virginia has reached 11, officials said.
-
All you need to know about the swine flu vaccine Nov 18, 2009 @ 06:15 AM
Worried about the swine flu vaccine? Andrew Pekosz, an associate professor of molecular microbiology and immunology at Johns Hopkins University's Bloomberg School of Public Health in Baltimore, was online Thursday, Oct. 22 at 11 a.m. ET to answer questions about the H1N1 swine flu vaccine.
